ArticlePathology oncology research : POR2020

Loss of CHEK2 Predicts Progression in Stage pT1 Non-Muscle-Invasive Bladder Cancer (NMIBC).

Philipp J Spachmann et al.PubMed ↗Publisher ↗

No numbers read from the abstract.